Sun Pharma Advanced Research Company Ltd share price logo

Sparc Share Price

(SPARC)

₹121.76▲2.3%

as on 04:01PM, 27 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Sparc Performance

  • Day's Low

    Day's High

    ₹119.58
    Day's Price Range
    ₹125.04

  • 52 Week's Low

    52 Week's High

    ₹119.58
    52-Week Price Range
    ₹472.8
1 Month Return-24.53 %
3 Month Return-40.37 %
1 Year Return-63.86 %
Previous Close₹124.63
Open₹125.00
Volume10.61L
Upper Circuit-
Lower Circuit-
Market Cap₹4,044.51Cr

Sparc Key Statistics

P/E Ratio

-10.4

PEG Ratio

13.69

Market Cap

₹4,044.51 Cr

P/B Ratio

96.09

EPS

-11.93

Dividend Yield

0

Sector

Pharmaceuticals

ROE

0

Key events for Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Faces Significant Losses - 18 Feb, 2025

    Sun Pharma Advanced Research Company shares hit a 52-week low, declining 19% over nine sessions. Rekha Jhunjhunwala reduced her stake to 1.6%. The company reported a net loss of ₹387 crore for FY24, continuing its trend of losses for eight years. Despite a slight revenue increase, the stock has dropped 35.2% in 2025.

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.10% to 0.51% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.15% to 2.23% in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 120.5% return, outperforming this stock by 174.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 61.8% return, outperforming this stock by 125.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 31.95% to 31.46% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SPARC stock has moved down by -7.9%

Sparc Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹13.86Cr (-)₹16.56Cr (↑19.48%)₹16.81Cr (↑1.51%)₹12.86Cr (↓23.50%)₹14.91Cr (↑15.94%)
Net Income-₹99.65Cr (-)-₹105.79Cr (↑6.16%)-₹95.90Cr (↓9.35%)-₹107.33Cr (↑11.92%)-₹79.51Cr (↓25.92%)
Net Profit Margin-718.98% (-)-638.83% (↓11.15%)-570.49% (↓10.70%)-834.60% (↑46.30%)-533.27% (↓36.10%)
Value in ₹ crore
Details2021202220232024
Total Assets₹229.70Cr (-)₹280.08Cr (↑21.93%)₹830.12Cr (↑196.39%)₹486.34Cr (↓41.41%)
Total Liabilities₹397.95Cr (-)₹248.85Cr (↓37.47%)₹317.35Cr (↑27.53%)₹361.49Cr (↑13.91%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹210.81Cr (-)-₹151.90Cr (↓27.94%)-₹208.23Cr (↑37.08%)-₹69.12Cr (↓66.81%)-₹429.43Cr (↑521.28%)

Index Inclusions

Nifty Smallcap 250

₹14,200.20

-1.67 (▲-241.5%)

S&P BSE 400 MidSmallCap

₹10,207.99

-1.17 (▲-121.17%)

BSE 500

₹31,964.79

-0.49 (▲-157.92%)

S&P BSE 250 SmallCap

₹5,704.98

-1.63 (▲-94.46%)

Nifty MidSmallcap 400

₹16,740.55

-1.4 (▲-238.35%)

Nifty 500

₹20,315.55

-0.51 (▲-103.2%)

BSE Healthcare

₹39,066.63

-0.72 (▲-283.87%)

BSE Small-Cap

₹44,111.64

-2.09 (▲-940.57%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Sparc Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
2.23%
3.79
Mutual Funds
0.51%
388.02
Retail Investors
31.46%
-1.53
Others
0.13%
4.48

Sparc Key Indicators

Details2024
Return On Assets %-79.62
Details2024
Book Value Per Share (₹)3.88
Details2024
Earning Per Share (₹)-11.93

Sparc Valuation

Sparc in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-10.40x)

February 25, 2025

Industry (50.89x)

February 25, 2025

Highest (0.00x)

December 29, 2023

LowHigh

Sparc Earnings and Dividends

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 20.21% since last year same period to ₹-79.51Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 25.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

Sparc Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sun Pharma Advanced Research Company Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Sparc Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹4,044.51 Cr-4%0.79-₹388 Cr₹75 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹30,774.36 Cr123.46%0.52₹300 Cr₹1,051 Cr
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹14,950.31 Cr21.38%0.57₹72 Cr₹6,702 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹13,498.25 Cr39.05%0.68₹218 Cr₹1,296 Cr
Poly Medicure Ltd
Poly Medicure Ltd
BUY₹22,102.69 Cr125.52%0.55₹258 Cr₹1,375 Cr
See all

About Sparc

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Share Price: ₹121.76 per share as on 27 Feb, 2025 04:01 PM
Market Capitalisation: ₹4,044.51Cr as of today
Revenue: ₹14.91Cr as on December 2024 (Q4 24)
Net Profit: ₹-79.51Cr as on December 2024 (Q4 24)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSparc
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Sun Pharma Advanced Research Company Ltd

What is Sun Pharma Advanced Research Company Ltd price today?

Sun Pharma Advanced Research Company Ltd share price today stands at ₹121.76, Open: ₹125, Previous Close: ₹124.63, High: ₹125.04, Low: ₹119.58, 52 Week High: ₹472.8, 52 Week Low: ₹119.58.

How to Buy Sun Pharma Advanced Research Company Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Sun Pharma Advanced Research Company Ltd shares

Is Sun Pharma Advanced Research Company Ltd listed on NSE?

Sun Pharma Advanced Research Company Ltd is listed on NSE

Is Sun Pharma Advanced Research Company Ltd listed on BSE?

Sun Pharma Advanced Research Company Ltd is listed on BSE

What are today's High and Low prices of Sun Pharma Advanced Research Company Ltd?

  • Today's highest price of Sun Pharma Advanced Research Company Ltd is ₹125.04.
  • Today's lowest price of Sun Pharma Advanced Research Company Ltd is ₹119.58.

What are today's traded volumes of Sun Pharma Advanced Research Company Ltd?

Today's traded volume of Sun Pharma Advanced Research Company Ltd(SPARC) is 10.61L.

What is today's market capitalisation of Sun Pharma Advanced Research Company Ltd?

Today's market capitalisation of Sun Pharma Advanced Research Company Ltd(SPARC) is ₹4044.51Cr.

What is the 52 Week High and Low Range of Sun Pharma Advanced Research Company Ltd?

Sun Pharma Advanced Research Company Ltd (SPARC)
Price
52 Week High
₹472.8
52 Week Low
₹119.58

How much percentage Sun Pharma Advanced Research Company Ltd is down from its 52 Week High?

Sun Pharma Advanced Research Company Ltd (SPARC) share price is ₹121.76. It is down -74.25% from its 52 Week High price of ₹472.8

How much percentage Sun Pharma Advanced Research Company Ltd is up from its 52 Week low?

Sun Pharma Advanced Research Company Ltd (SPARC) share price is ₹121.76. It is up 1.82% from its 52 Week Low price of ₹119.58

What are the historical returns of Sun Pharma Advanced Research Company Ltd?

Sun Pharma Advanced Research Company Ltd (SPARC)
Returns
1 Day Returns
-2.87%
1 Month Returns
-24.53%
3 Month Returns
-40.37%
1 Year Returns
-63.86%

What is the PE ratio of Sun Pharma Advanced Research Company Ltd today?

PE Ratio of Sun Pharma Advanced Research Company Ltd is -10.4

PE ratio = Sun Pharma Advanced Research Company Ltd Market price per share / Sun Pharma Advanced Research Company Ltd Earnings per share